Not So Different: A Podcast From The Center For Biosimilars

Show notes US Welcomes First Adalimumab Biosimilar, Amjevita https://www.centerforbiosimilars.com/view/us-welcomes-first-adalimumab-biosimilar-amjevita  Canada Approves High-Concentration Humira Biosimilar https://www.centerforbiosimilars.com/view/canada-approves-high-concentration-humira-biosimilar  Celltrion Submits BLA for Infliximab Biobetter https://www.centerforbiosimilars.com/view/celltrion-submits-bla-for-infliximab-biobetter  FDA Accepts BLA for Alvotech Ustekinumab Biosimilar https://www.centerforbiosimilars.com/view/fda-accepts-bla-for-alvotech-ustekinumab-biosimilar  Biosimilars Check-in: Approval in Saudi Arabia, Launch in Republic of Korea, Dr. Reddy’s Completes Study https://www.centerforbiosimilars.com/view/biosimilars-check-in-approval-in-saudi-arabia-launch-in-republic-of-korea-dr-reddy-s-completes-study  China's NMPA Approves Tocilizumab Biosimilar https://www.centerforbiosimilars.com/view/china-s-nmpa-approves-tocilizumab-biosimilar   US Welcomes First Adalimumab Biosimilar, Amjevit